Received Mar 3, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| FLU3 | INFLUENZA (SEASONAL) (FLUARIX) | GLAXOSMITHKLINE BIOLOGICALS | UNK | 3p993 | — |
| FLU4 | INFLUENZA (SEASONAL) (FLUARIX QUADRIVALENT) | GLAXOSMITHKLINE BIOLOGICALS | UNK | UNK | — |
Rash on back and legs; This non-serious case was reported by a consumer and described the occurrence of rash in a 84-year-old female patient who received Flu Seasonal QIV Dresden (Fluarix Quadrivalent 2024-2025 season) for prophylaxis. Concurrent medical conditions included sensitive skin. On 04-NOV-2024, the patient received Fluarix Quadrivalent 2024-2025 season. On an unknown date, an unknown time after receiving Fluarix Quadrivalent 2024-2025 season, the patient experienced rash (Verbatim: Rash on back and legs). The outcome of the rash was not resolved. It was unknown if the reporter considered the rash to be related to Fluarix Quadrivalent 2024-2025 season and Fluarix Tetra Pre-Filled Syringe Device. It was unknown if the company considered the rash to be related to Fluarix Quadrivalent 2024-2025 season and Fluarix Tetra Pre-Filled Syringe Device. This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences. Additional Information: GSK Receipt Date: 07-FEB-2025 This was the patient's second request for assistance on this matter. The patient need information on contents of this vaccine to know if the patient was allergic to some. The patient had sensitive skin and wanted to prevent further issues with any future injections for flu or any other conditions. The reporter consented to follow up.
Sensitive skin